the partners of Innov-CKD

DIRCOM-Tuile-Partenaires-Innovckd.jpg

Aix-Marseille University

The largest French-speaking university, Aix-Marseille University (AMU) welcomes 78,000 students and nearly 8,000 staff on 5 large campuses of international standards. Owner of its heritage, the university is present in 9 major cities in 4 departments. Its A*Midex University Foundation, which is the permanent home of IDEX, contributes to the development of a world-class multidisciplinary and interdisciplinary higher education and research centre.

APHM - Assistance Publique Hôpitaux de Marseille (Public Assistance Hospitals of Marseille)

With 4 hospitals and 3,400 beds, the AP-HM is the 3rd largest University Hospital Center in France. It is also the largest employer in the region, with more than 12,000 employees and nearly 2,000 doctors. Its missions are care, training, research, prevention and health education. Its establishments offer the full range of specialities, from local care to cutting-edge treatment of complex and rare pathologies, for adults and children. Its medical and care teams are committed to providing excellent and local care, accessible to all.

STAGO

Stago specialises in the fields of Haemostasis and Thrombosis, and today devotes all its research and innovation efforts to the development of ever more effective biological diagnostic products and tools. A player in the field for over 60 years, Stago has a first-rate experience in Haemostasis recognised by the international scientific community.

BioCytex

BioCytex, a biotechnology company created in the early 1990s, became part of the Stago Group in 1994. The BioCytex subsidiary specialises in the development of standardised flow cytometry kits in the field of Haemostasis. Since its creation near the university hospital complex of La Timone / La Conception in Marseille, BioCytex has been interested in standardization in flow cytometry. Inter-laboratory reproducibility, reproducibility over time, determination of positivity and/or negativity thresholds are important parameters that can be determined using quantitative flow cytometry. This is the expertise of Biocytex. Since its first commercial success (QIFIKIT®), BioCytex has focused on improving its quantitative flow cytometry technique and adapting it to the analysis of blood platelets (PLATELET range), leukocytes and red blood cells (CELLQUANT & REDQUANT ranges).

Keywords
Aix-Marseille University
APHM
Stago
BioCytex
Innov-CKD Partners